FAGOONEE, SHARMILA
 Distribuzione geografica
Continente #
NA - Nord America 4.992
EU - Europa 2.802
AS - Asia 1.430
AF - Africa 105
SA - Sud America 92
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 6
Totale 9.466
Nazione #
US - Stati Uniti d'America 4.879
CN - Cina 808
IT - Italia 779
IE - Irlanda 343
SE - Svezia 291
UA - Ucraina 201
DE - Germania 187
FR - Francia 186
FI - Finlandia 117
GB - Regno Unito 116
DK - Danimarca 113
VN - Vietnam 113
PL - Polonia 99
IN - India 87
KR - Corea 85
AT - Austria 74
CA - Canada 72
TR - Turchia 66
ES - Italia 53
BR - Brasile 48
HK - Hong Kong 48
JP - Giappone 39
IR - Iran 36
BE - Belgio 33
MX - Messico 33
RU - Federazione Russa 33
AU - Australia 32
NL - Olanda 31
RO - Romania 26
GR - Grecia 25
EG - Egitto 23
SG - Singapore 23
SN - Senegal 21
TW - Taiwan 21
PT - Portogallo 19
HU - Ungheria 18
PK - Pakistan 16
DZ - Algeria 15
NG - Nigeria 15
IL - Israele 14
CO - Colombia 13
MY - Malesia 13
CZ - Repubblica Ceca 12
AR - Argentina 11
PE - Perù 11
PH - Filippine 10
TH - Thailandia 10
CH - Svizzera 9
AE - Emirati Arabi Uniti 8
LT - Lituania 8
BG - Bulgaria 7
ID - Indonesia 7
BA - Bosnia-Erzegovina 6
JO - Giordania 6
NZ - Nuova Zelanda 6
ET - Etiopia 5
EU - Europa 5
NO - Norvegia 5
TN - Tunisia 5
CL - Cile 4
CU - Cuba 4
IQ - Iraq 4
MA - Marocco 4
SA - Arabia Saudita 4
ZA - Sudafrica 4
BO - Bolivia 3
BY - Bielorussia 3
KE - Kenya 3
KW - Kuwait 3
PS - Palestinian Territory 3
TD - Ciad 3
BD - Bangladesh 2
HR - Croazia 2
LU - Lussemburgo 2
PA - Panama 2
SD - Sudan 2
AP - ???statistics.table.value.countryCode.AP??? 1
BF - Burkina Faso 1
CR - Costa Rica 1
EC - Ecuador 1
EE - Estonia 1
GN - Guinea 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
PG - Papua Nuova Guinea 1
PR - Porto Rico 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
VE - Venezuela 1
ZM - Zambia 1
Totale 9.466
Città #
Ann Arbor 686
Chandler 619
Beijing 379
Houston 354
Dublin 343
Fairfield 319
Torino 275
Ashburn 224
Wilmington 165
Jacksonville 158
Woodbridge 138
Seattle 116
Villeurbanne 111
Princeton 108
Cambridge 102
Medford 102
Nyköping 92
Redwood City 90
Dearborn 89
Warsaw 86
Pisa 84
Vienna 72
Turin 68
Dong Ket 67
Fremont 57
Guangzhou 45
Milan 45
Boston 43
Shanghai 40
Hangzhou 39
San Diego 33
Nanjing 30
Boardman 25
New York 24
Ottawa 23
Washington 23
Istanbul 22
Detroit 20
Toronto 19
Upper Marlboro 19
Helsinki 17
Brussels 16
Chennai 16
Central 15
Hyderabad 15
Norwalk 15
Seoul 15
Zhengzhou 15
Phoenix 14
Rome 14
Chengdu 13
Chicago 13
Silver Spring 13
Zapopan 13
Central District 12
Hefei 12
Heidelberg 12
San Mateo 12
Tehran 12
Thessaloniki 12
Los Angeles 11
Nanchang 11
Taipei 11
Tokyo 11
Falls Church 10
Hebei 10
Jinan 10
Kunming 10
Lima 10
Munich 10
Düsseldorf 9
Hong Kong 9
Odense 9
São Paulo 9
Abuja 8
Changsha 8
Jena 8
Rio De Janeiro 8
Verona 8
Amsterdam 7
Barcelona 7
Bologna 7
Chongqing 7
Dubai 7
Duncan 7
Louvain 7
Medellín 7
Montréal 7
Nanning 7
Ningbo 7
San Sebastián de los Reyes 7
Wuhan 7
Xian 7
Coventry 6
Des Moines 6
Iasi 6
Lanzhou 6
Lisbon 6
London 6
Madrid 6
Totale 5.950
Nome #
Management of Helicobacter pylori in Piedmont, Italy 292
Endocrine manifestations of chronic HCV infection 271
Differential diagnosis of pancreatic cysts: A prospective study on the role of intra-cystic glucose concentration 254
Liver Sinusoidal Endothelial Cells at the Crossroad of Iron Overload and Liver Fibrosis 230
Severe ulcerative colitis: predictors of response and algorithm proposal for rescue therapy 214
Plasma protein haptoglobin modulates renal iron loading 212
Physiopathology of intestinal barrier and the role of zonulin 204
The RNA-binding protein ESRP1 promotes human colorectal cancer progression 202
Liver fibrosis: the 2017 state of art 190
Helicobacter pylori infection and ischemic heart disease: could experimental data lead to clinical studies? 188
Enhanced splenomegaly and severe liver inflammation in haptoglobin/hemopexin double null mice after acute hemolysis 180
Risk of microangiopathy in type 2 diabetes mellitus patients with or without chronic hepatitis C: Results of a retrospective long-term controlled cohort study 178
Noninvasive diagnosis of fibrosis in non-alcoholic fatty liver disease: diagnostic accuracy of different scores 177
The mitochondrial heme exporter FLVCR1b mediates erythroid differentiation 174
Current treatment challenges in the COVID-19 pandemic 171
2013 update on celiac disease and eosinophilic esophagitis 160
Generation of Functional Hepatocytes from Mouse Germline Cell-derived Pluripotent Stem Cells in vitro 151
Microscopic colitis in patients with mild duodenal damage: A new clinical and pathological entity ("lymphocytic enterocolitis")? 147
Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study 144
Gastric emptying and related symptoms in patients treated with buspirone, amitriptyline or clebopride: a "real world" study by 13C-octanoic acid breath test 132
A composite enhancer regulates p63 gene expression in epidermal morphogenesis and in keratinocyte differentiation by multiple mechanisms 131
Helicobacter pyloriinfection and asthma: Is there a direct or an inverse association? A meta-analysis 131
Prospects for adult stem cells in the treatment of liver diseases 131
Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report 129
Is Helicobacter pylori the infectious trigger for headache?: A review 128
Long Term Liver Engraftment of Functional Hepatocytes Obtained from Germline Cell-Derived Pluripotent Stem Cells 126
Re: El-Garem et al.: Seminal Helicobacter pylori Treatment Improves Sperm Motility in Infertile Asthenozoospermic Men (Urology 2014;84:1347-1350). 124
A 2016 panorama of Helicobacter pylori infection: key messages for clinicians 122
Characterization of Human Mesenchymal Stem Cells Isolated from the Testis 120
Basic and clinical aspects of resistin 114
Laboratory evidence of Helicobacter species infection in hepatocellular carcinoma 112
Higher Efficiency of Percutaneous Microwave (MWA) Than Radiofrequency Ablation (RFA) in Achieving Complete Response in Cirrhotic Patients with Early Hepatocellular Carcinoma 107
Human liver stem cells express UGT1A1 and improve phenotype of immunocompromised Crigler Najjar syndrome type I mice 106
Rifabutin-Based Rescue Therapy for Helicobacter pylori Eradication: A Long-Term Prospective Study in a Large Cohort of Difficult-to-Treat Patients 106
COVID-19: a user's guide, status of the art and an original proposal to terminate viral recurrence 104
ETIOLOGY OF CHRONIC LIVER DISEASES IN THE NORTHWEST OF ITALY, 1998 THROUGH 2014 101
Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1 101
On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases 100
Endoscopic ultrasound in the preoperative staging of gastric cancer: Key messages for surgeons 94
Incidence of Prostate Cancer in Inflammatory Bowel Disease: A Meta-Analysis 93
Comments on Umer Draz et al. (J Pak Med Assoc. 2018; 68: 939-41) Presence of pre-diabetes in Helicobacter pylori positive versus Helicobacter pylori negative patients having dyspepsia 90
Comment on "Changes in acute viral hepatitis epidemiology in the Turkish adult population: A multicenter study" 90
Efficacy of amoxycillin and clarithromycin-based triple therapy for Helicobacter pylori eradication: a 10-year trend in Turin, Italy 90
A dive into the stem cells world 86
Proteomics-based evidence for a pro-oncogenic role of ESRP1 in human colorectal cancer cells 86
Evolving Cell-Based and Cell-Free Clinical Strategies for Treating Severe Human Liver Diseases 85
Efficacy and safety of long-term entecavir therapy in a european population 84
Coxib's Safety in Patients with Inflammatory Bowel Diseases: A Meta-analysis 84
Role and function of exosomal miR-9-3p in hepatocellular carcinoma 83
The first-line treatment of Helicobacter pylori infection in Piedmont in the year 2017 83
Type 2 diabetes mellitus and chronic hepatitis C: Which is worse? Results of a long-term retrospective cohort study. 81
Prevalence and prognostic value of hepatic histological alterations in patients with Crohn's disease 78
Amoxycillin plus tetracycline as first-line Helicobacter pylori treatment. 74
How accurate is the culture of Helicobacter pylori in a clinical setting? An appraisal 74
Modulation of the gut microbiota: opportunities and regulatory aspects 73
Heme scavenging and the other facets of hemopexin 73
Hepatitis B Core-Related Antigen as Surrogate Biomarker of Intrahepatic Hepatitis B Virus Covalently-Closed-Circular DNA in Patients with Chronic Hepatitis B: A Meta-Analysis 73
History of Inflammatory Bowel Diseases 72
Endoscopic imaging in the management of gastroenteropancreatic neuroendocrine tumors 71
HOTAIR and gastric cancer: A lesson from two meta-analyses 68
Asthma and gastroesophageal reflux disease: A multidisciplinary point of view 67
Clinical and biochemical parameters related to cardiovascular disease after Helicobacter pylori eradication 66
Gastrointestinal tract disorders in the elderly 65
Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel Diseases 65
The RNA binding protein ESRP1 fine-tunes the expression of pluripotency-related factors in mouse embryonic stem cells 60
Negative predictive value of endoscopic ultrasound in patients referred for fine-needle aspiration. 58
Renal Cells from Spermatogonial Germline Stem Cells Protect against Kidney Injury 58
Colorectal cancer detection in an asymptomatic population: Fecal immunochemical test for hemoglobin vs. Fecal M2-type pyruvate kinase 57
Lack of haptoglobin affects iron transport across duodenum by modulating ferroportin expression 57
Long-term follow-up of diabetic and non-diabetic patients with chronic hepatitis C successfully treated with direct-acting antiviral agents 57
The role of gastroesophageal reflux disease in chest pain. 55
Management of primary biliary cholangitis prior to obeticholic acid availability. 55
Tissue stem cells and cancer stem cells: potential implications for gastric cancer 54
Haemopexin affects iron distribution and ferritin expression in mouse brain 54
Lack of plasma protein hemopexin dampens mercury-induced autoimmune response in mice 52
Circulating Extracellular Vesicles Contain Liver-Derived RNA Species as Indicators of Severe Cholestasis-Induced Early Liver Fibrosis in Mice 50
Impact of Macroscopic On-Site Evaluation (MOSE) on Accuracy of Endoscopic Ultrasound-Guided Fine-Needle Biopsy (EUS-FNB) of Pancreatic and Extrapancreatic Solid Lesions: A Prospective Study 49
Lack of association between seroprevalence of Helicobacter pylori infection and primary biliary cirrhosis 47
Safety of propofol in cirrhotic patients undergoing colonoscopy and endoscopic retrograde cholangiography: results of a prospective controlled study. 47
A Retrospective Experience of Helicobacter pylori Histology in a Large Sample of Subjects in Northern Italy 47
Efficacy of azythromicin-based triple therapy for Helicobacter pylori infection: a retrospective study 46
Regenerative Approaches and Future Trends for the Treatment of Corneal Burn Injuries 46
Helicobacter pylori Resistance: A Medical Predictive Factor of Response 44
Stem cell world 2010: crucial questions from clinicians to biologists 43
Functional Antagonism between Sall4 and Plzf Defines Germline Progenitors 43
Helicobacter pylori eradication: metronidazole or tinidazole? Data from Turin, Italy. 42
Extra-Intestinal Manifestations of Celiac Disease. What Should We Know in 2022? 41
Protection against heme overload: Role of haptoglobin, hemopexin and heme oxygenase-I as evinced by the analysis of animal models. In AUTORI VARI Recent Research Developments 40
Potential applications of germline cell-derived pluripotent stem cells in organ regeneration 40
Molecular mechanisms of hepatic fibrosis in chronic liver diseases 40
Overlap syndromes of autoimmune hepatitis: what is known so far. 39
MicroRNAs in HBV-related hepatocellular carcinoma: functions and potential clinical applications 39
Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma 38
The rna-binding protein esrp1 modulates the expression of rac1b in colorectal cancer cells 36
Trends in the Comprehension and Management of Gastrointestinal Tract Disorders 36
null 35
Impedance-based drug-resistance characterization of colon cancer cells through real-time cell culture monitoring 34
Haptoglobin modifies the hemochromatosis phenotype in mice 33
Helicobacter pylori and respiratory diseases: 2021 update 32
Phenotypic and functional characterization of aqueous humor derived extracellular vesicles 32
Totale 9.648
Categoria #
all - tutte 26.380
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.380


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019248 0 0 0 0 0 0 0 0 0 0 178 70
2019/20201.436 59 43 47 142 78 268 163 124 169 110 127 106
2020/20211.303 78 113 106 109 110 104 87 88 126 104 75 203
2021/20221.958 98 88 89 129 98 97 261 248 152 174 275 249
2022/20232.166 218 176 73 147 205 466 183 130 281 65 118 104
2023/20241.002 144 184 83 60 101 113 77 136 7 89 8 0
Totale 9.858